Plain-English translation of NCT07784725 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a large study testing whether a medication called can help adults with overweight or obesity lose weight and improve their health. The medication is given as a weekly injection under the skin. Researchers will compare the medication to placebo (a dummy injection) to see if it actually works.
Many people struggle to lose weight on their own, even with diet and exercise, and excess weight can lead to serious health problems like high blood pressure, heart disease, and joint damage. This trial is testing whether this new treatment could help people manage their weight and reduce these health risks.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to receive either the new medication or a placebo injection once a week. You'll visit the study clinic regularly for check-ups, blood tests, and to receive your injections. The study involves about 2,500 participants across multiple locations worldwide, and researchers will track your weight, health improvements, and any side effects over time.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
United States